In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Gray Sheet

Executive Summary

ResMed appoints CEO: Kieran T. Gallahue will take the top spot at the sleep and respiratory device firm and join the board of directors on Jan. 1, 2008. Gallahue, who is being promoted to the position from his role as president and chief operating officer of ResMed Global, succeeds company founder Peter C. Farrell. Before Gallahue joined ResMed in 2003 as president and COO of the Americas, he served as president of diagnostics firm Nanogen. Farrell will continue as executive chairman of the board until June 30, 2008, when he will become non-executive chairman...

Latest Headlines
See All
UsernamePublicRestriction

Register

MT025211

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel